Finance

Lists
PPLPHARMA:NSE
Piramal Pharma Ltd (Mumbai)
238,92 INR
+0,12%
(+0,29) 1D
6-ноя., 15:30:02 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PPLPHARMA...
Open
238,80 INR
High
240,00 INR
Low
235,12 INR
Mkt. cap
315,90 млд
Avg. vol.
8,45 млн
Volume
2,85 млн
52-wk high
243,20 INR
52-wk low
132,30 INR
EPS
-1,58 INR
No. of employees
7 миң
Open
238,80 INR
High
240,00 INR
Low
235,12 INR
Mkt. cap
315,90 млд
Avg. vol.
8,45 млн
Volume
2,85 млн
52-wk high
243,20 INR
52-wk low
132,30 INR
EPS
-1,58 INR
No. of employees
7 миң
News stories
From web sources and news partners
About Piramal Pharma Ltd (Mumbai)
CEOPeter DeYoung
Employees7,12 миң
Founded2020
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
2026-ж., 28-окт.
Fiscal period
Q2 2027
0,04 INR / -0,38 INR
+110,57%beat
Revenue / Est. (INR)
26,17 млд / 23,58 млд
+11,00%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
21,40 млд
27,52 млд
22,70 млд
26,17 млд
Cost of goods sold
7,86 млд
13,95 млд
8,52 млд
9,06 млд
Cost of revenue
7,86 млд
13,95 млд
8,52 млд
9,06 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,00 млд
8,19 млд
6,76 млд
7,14 млд
Operating expense
13,71 млд
11,09 млд
14,46 млд
15,95 млд
Total operating expenses
21,57 млд
25,04 млд
22,98 млд
25,01 млд
Operating income
-170,10 млн
2,47 млд
-283,50 млн
1,16 млд
Other non operating income
432,40 млн
-977,90 млн
894,10 млн
359,30 млн
EBT including unusual items
-938,60 млн
430,00 млн
-74,60 млн
816,30 млн
EBT excluding unusual items
-527,50 млн
1,40 млд
-74,60 млн
816,30 млн
Income tax expense
423,30 млн
518,30 млн
619,30 млн
766,00 млн
Effective tax rate
-45,10%
120,53%
-830,16%
93,84%
Other operating expenses
5,58 млд
723,30 млн
5,47 млд
6,48 млд
Net income
-1,36 млд
-88,30 млн
-693,90 млн
55,80 млн
Net profit margin
-6,36%
-0,32%
-3,06%
0,21%
Earnings per share
-0,72
1,32
-0,52
0,04
Interest and investment income
-
70,70 млн
-
-
Interest expense
-892,40 млн
-805,40 млн
-880,80 млн
-876,30 млн
Net interest expenses
-892,40 млн
-734,70 млн
-880,80 млн
-876,30 млн
Depreciation and amortization charges
2,13 млд
2,18 млд
2,24 млд
2,33 млд
EBITDA
1,68 млд
4,32 млд
1,57 млд
3,29 млд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору